Clinical Trial Update: Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia [Phase 2]

View source ↗

Summary

This Phase 2 trial of ONO-5046Na in patients with acute respiratory failure due to community-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• ONO-5046Na (ONO-5046Na)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Community-acquired Pneumonia | Phase 2 | Status: COMPLETED